YPF (YPF) hits new 52-week high after J.P. Morgan upgrades, citing growth opportunities in Argentina's energy industry.

SkyWest's strong fundamentals include predictable revenues from capacity purchase agreements, consistent debt reduction, and ...

Insmed (INSM) reported preliminary 2024 revenue results for its drug Arikayce and issued 2025 revenue guidance. Read more ...

AMD’s AI advancements are overshadowed by Nvidia’s CUDA. Find out why AMD stock is overvalued, while NVDA continues to lead the AI and data center space.

“We see more good than bad happening in 2025 and believe this will cause Softline’s’ valuation gap vs the S&P 500 to narrow, ...

Is IBM's software business growth underestimated due to AI expansion? Its P/E ratio has increased significantly, impacting ...

NuScale's regulatory approval for SMRs in the U.S. gives it a unique market position, with a major project to go live in 2029 ...

Sanofi’s Dupixent and new drugs drive growth, despite near-term pressures. See why SFY stock’s product pipeline makes it a ...

US job growth surged in December, surpassing expectations. The services sector drove gains, but wage growth slightly slowed.

Beta Bionics is commercializing innovative insulin delivery technologies, but faces challenges in achieving profitability.

Microsoft’s focus on long-term AI success explains recent stock behavior. See why MSFT stock, with recent reallocations, is ...

The Hershey Company is a strong hold, but Mondelez offers growth potential. See why HSY and MDLZ stocks could offer better ...